Us dental membrane and bone graft substitutes market

U.S. Dental Membrane and Bone Graft Substitutes Market, by Product Type (Dental Membrane (Resorbable Membranes and Non-resorbable Membranes) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, and Synthetic Bone Graft Substitute)), by Material (Collagen, Hydrogel, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene, Human Cells Source, and Others), by Application (Socket Preservation, Ridge Augmentation, Sinus Lifts, Guided Bone Regeneration (GBR), and Guided Tissue Regeneration (GTR)), and by End User (Hospitals, Dental Clinics, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Request Free Sample

Nov 2021
CMI4749
222 Pages
Excel & Pdf
Medical Devices

Summary

Dental membranes and bone graft substitutes are used for dental bone regeneration procedures in patients affected by oral health disorders such as periodontal diseases and oral cancer. Dental membranes are used alongside dental bone grafts to allow cell proliferation. Major factors contributing to growth of the dental membrane and bone graft substitutes market are growing number of oral health issues, increasing product launches, and rising dental health expenditure. For instance, in April 2018, Geistlich Pharma North America Inc. announced the launch of two new resorbable collagen membranes Geistlich Bio-Gide Compressed and Geistlich Bio-Gide Shape.

The U.S. dental membrane and bone graft substitutes market is estimated to be valued at US$ 171.9 million in 2021 and is expected to exhibit a CAGR of 9.9% during the forecast period (2021-2028).

Figure 1. U.S. Dental Membrane and Bone Graft Substitutes Market Share in Terms of Value (US$ Mn), By Product Type, 2021

Increasing oral health diseases is expected to drive the market growth over the forecast period.

Increasing oral health diseases such as cavities and gum disease is the leading factor for growth of dental membrane and bone graft substitutes market across the globe. The factors leading to oral health issue includes unhealthy diet, tobacco use, excess alcohol consumption, and poor oral hygiene. For instance, according to the Centers for Disease Control and Prevention report 2019-2020, in the U.S., more than a quarter (26%) of adults had untreated tooth decay and almost half (46%) of all adults 30 years and older had signs of gum disease.

U.S. Dental Membrane and Bone Graft Substitutes Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 171.9 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	9.9%	2028 Value Projection:	US$ 333.6 Mn
Geographies covered:	North America: U.S.
Segments covered:	By Product Type: Dental Membrane (Resorbable Membranes, Non-resorbable Membranes), Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Synthetic Bone Graft Substitute) By Material: Collagen, Hydrogel, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene, Human Cells Source, Others By Application: Socket Preservation, Ridge Augmentation, Sinus Lifts, Guided Bone Regeneration (GBR), Guided Tissue Regeneration (GTR) By End User: Hospitals, Dental Clinics, Others
Companies covered (8):	Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical, and Sun Pharmaceutical Industries Ltd.
Growth Drivers:	Disease outbreaks such as coronavirus disease (COVID 19) High prevalence of malaria and rheumatoid arthritis Increasing product launches and approvals
Restraints & Challenges:	Lack of evidences associated with the treatment coronavirus disease (COVID 19)

Figure 2. U.S. Dental Membrane and Bone Graft Substitutes Market Share (%), By Application, 2021

Increasing product launches is expected to drive the market growth during the forecast period.

Increasing demand for efficient implants and membrane for dental restoration due to increasing oral health issues is expected to propel growth of the U.S. dental membrane and bone graft substitute market during the forecast period. In order to cater to increasing demand, manufacturers are focusing on developing new and highly efficient products included in implants and restoration. For instance, in February 2019, Zimmer Biomet Holdings, a global healthcare company, announced the expansion of its dental product portfolio to include non-resorbable membranes and sutures. The new OsseoGuard non-resorbable product line includes dense PTFE (polytetrafluoroethylene) membranes in multiple texture variations as well as titanium mesh and PTFE sutures. OsseoGuard products are currently available in the U.S. and Canada.

U.S. Dental Membrane and Bone Graft Substitutes Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper growth of the U.S. dental membrane and bone graft substitutes market during the forecast period. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 43 million cases and 0.69 million deaths due to coronavirus (COVID-19) were reported up till September 23, 2021, across the U.S.

Furthermore, the decrease in patients visiting dental clinics is a major challenge faced during the pandemic. For instance, according to the report published by the American Dental Association (ADA), April 2020, the COVID-19 pandemic had a significant impact on the dental care industry in the U.S. Over three-fourths of dental practices in the U.S. saw only emergency patients, and another 18% were completely closed. Moreover, according to the same source, the vast majority of dentists reported that their total collection volume was less than 5% of what is typical. Moreover, according to ADA's analysis, there was a 66% reduction in the U.S. dental spending in 2020 compared to pre-pandemic projections, which could lead to 32% reduction of dental spending in 2021.

U.S. Dental Membrane and Bone Graft Substitutes Market: Restraint

The high cost of dental membranes and bone grafts is expected to impede the U.S. dental membranes and bone graft substitutes market growth over the forecast period. The cost of a bone graft can vary substantially depending on the case and the condition of the patient’s jawbone. The typical costs associated with simple bone grafting for dental purposes using synthetic bone can cost between US$ 300 and US$ 800 for a single implant area.

Key Players

Major players operating in the U.S. dental membrane and bone graft substitutes market include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.

Table of Content

*Browse 25 market data tables and 30 figures on "U.S. Dental Membrane and Bone Graft Substitutes Market” - forecast to 2028

N/A

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2021-2028)?

The U.S. dental membrane and bone graft substitutes market is estimated to be valued at US$ 171.9 million in 2021 and is expected to exhibit a CAGR of 9.9% between 2021 and 2028.

What are the major factors driving the market growth?

Factors such as increased spending on dental health and growing number of oral health issues are expected to drive the market growth during the forecast period.

Which is the leading product type segment in the market?

Bone graft substitutes product type segment is expected to hold a major market share during the forecast period in the market.

What are the key factors hampering growth of the market?

The major factor hampering growth of the market include stringent government regulations and high cost of products and procedures.

Which are the major players operating in the market?

Major players operating in the market include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.